Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Solazyme Inc    SZYM   US83415T1016

SOLAZYME INC (SZYM)

23
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/14/2014 10/15/2014 10/16/2014 10/17/2014 10/20/2014 Date
5.67(c) 6.96(c) 6.73(c) 6.25(c) 6.41 Last
1 382 960 2 927 710 3 017 400 1 855 269 939 622 Volume
+0.71% +22.75% -3.30% -7.13% +2.56% Change
More quotes
Company
Solazyme, Inc. is a renewable oil company, which is engaged in the industrial biotechnology.The company's technology allows algae to produce oils and biomaterials in standard fermentation facilities.Its oils and biomaterials are used for bio-fuel production and replacements for fossil petroleum and... 
Sector
Renewable Fuels
Calendar
11/05Earnings Release
Surperformance© rating of Solazyme Inc
Trading Rating : Investor Rating :
More about the company
Chart SOLAZYME INC
Duration : Period :
Solazyme Inc Technical Analysis Chart | SZYM | US83415T1016 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 88,8 M
EBIT 2014 -110 M
Net income 2014 -146 M
Debt 2014 214 M
Yield 2014 -
Sales 2015 275 M
EBIT 2015 -50,0 M
Net income 2015 -63,7 M
Debt 2015 339 M
Yield 2015 -
PER 2014 -
PER 2015
EV / Sales 2014 7,95x
EV / Sales 2015 3,02x
Capitalization 492 M
More Financials
Latest news on SOLAZYME INC
3d ago AMYRIS : EPA honors Calif. companies Amyris and Solazyme for using green chemist..
4d ago AMYRIS : U.S. EPA honors Calif. companies Amyris and Solazyme for using green ch..
6d ago SOLAZYME : Names David Cole a Strategic Advisor
10/10 SOLAZYME : Announces Transition of David Cole to Strategic Advisor
10/09 SOLAZYME : Change in Directors or Principal Officers (form 8-K)
10/09 SOLAZYME : Announces Appointment of Former DuPont CFO Gary Pfeiffer to the Board..
10/09 SOLAZYME : to Announce Third Quarter 2014 Financial Results on November 5, 2014
10/09 SOLAZYME : Announces Transition of David Cole to Strategic Advisor
10/09 Nasdaq stocks posting largest percentage decreases
10/02 SOLAZYME : Assigned Patent
09/12 SOLAZYME : to Participate in the 5th Annual Credit Suisse Small & Mid Cap Confer..
09/05 SOLAZYME : Assigned Patent
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF